[1]. Alzheimer’s Disease International. World Alzheimer Report 2019: Attitudes to Dementia. Alzheimer’s Disease International: London 2019.
[2]. Bagheri S, Saboury AA, Haertlé T, Rongioletti M, Saso L. Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid. Inorganics (Basel) 2022;10.
[3]. Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM. Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer’s disease. Neuroimage 2011;55:32–8.
[4]. Bagheri S, Saboury AA. What role do metals play in Alzheimer’s disease? Journal of the Iranian Chemical Society 2021;18.
[5]. Bagheri S, Squitti R, Haertlé T, Siotto M, Saboury AA. Role of copper in the onset of Alzheimer’s disease compared to other metals. Front Aging Neurosci 2018;9:446.
[6]. Fagiani F, Di Marino D, Romagnoli A, Travelli C, Voltan D, Mannelli LDC, et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther 2022;7.
[7]. Reddy Sujana, Reddy Vamsi, Sharma Sandeep. Physiology, Circadian Rhythm. vol. May. 2023.
[8]. Khan S, Nabi G, Yao L, Siddique R, Sajjad W, Kumar S, et al. Health risks associated with genetic alterations in internal clock system by external factors. Int J Biol Sci 2018;14.
[9] پیرحقی میترا، موسوی موحدی علی اکبر. ساعت زیستی بدن: رونمایی از ریتمهای حیات. نشاء علم، 1402;(2)13: 183-172.
[10]. Brenna A, Albrecht U. Phosphorylation and Circadian Molecular Timing. Front Physiol 2020;11.
[11]. O-Neill JS, Reddy AB. Circadian clocks in human red blood cells. Nature 2011;469.
[12]. Hua J, Zhuang S, Shen Y, Tang X, Sun H, Fang Q. Exploring the Bidirectional Associations Between Short or Long Sleep Duration and Lower Cognitive Function: A 7-Year Cohort Study in China. Front Aging Neurosci 2021;13.
[13]. Huang SY, Li YZ, Zhang YR, Huang YY, Wu BS, Zhang W, et al. Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK Biobank participants. Mol Psychiatry 2022;27.
[14]. Zhou X, Li J, Yu C, Fang W, Xie Y, Wang L, et al. Sex Modified the Association between Sleep Duration and worse Cognitive Performance in Chinese Hypertensive Population: Insight from the China H-Type Hypertension Registry Study. Behavioural Neurology 2022;2022.
[15]. Pillai JA, Bena J, Bekris LM, Foldvary-Schaefer N, Heinzinger C, Rao S, et al. Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer’s Disease with Mild Cognitive Impairment. Journal of Alzheimer’s Disease 2021;81.
[16]. Bedrosian TA, Nelson RJ. Pro: Alzheimer’s disease and circadian dysfunction: Chicken or egg? Alzheimers Res Ther 2012;4.
[17]. Rigat L, Ouk K, Kramer A, Priller J. Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer’s disease. Acta Physiologica 2023;238.
[18]. Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors. Neuropsychopharmacology 2020;45.
[19]. Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science (1979) 2016;354.
[20]. Li P, Gao L, Gaba A, Yu L, Cui L, Fan W, et al. Circadian disturbances in Alzheimer’s disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev 2020;1.
[21]. Kent BA, Feldman HH, Nygaard HB. Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer’s disease. Prog Neurobiol 2021;197.
[22]. Wei M, Zhao B, Huo K, Deng Y, Shang S, Liu J, et al. Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults. Journal of Alzheimer’s Disease 2017;57.
[23]. Lucey BP, Hicks TJ, Mcleland JS, Toedebusch CD, Boyd J, Elbert DL, et al. Effect of sleep on overnight CSF amyloid- β kinetics. Ann Neurol 2019;83.
[24]. Xu W, Tan L, Su BJ, Yu H, Bi YL, Yue XF, et al. Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: The CABLE study. Alzheimer’s and Dementia 2020;16.
[25]. Fu Y, Wang ZT, Qu Y, Wang XT, Ma YH, Bi YL, et al. Sleep Characteristics and Cognitive Function in Older Adults without Dementia: The CABLE Study. Journal of Alzheimer’s Disease 2021;84.
[26]. Kang J, Choi HJ, Isaacs GD, Sung W, Kim H-J. Amyloid Burden in Alzheimer’s Disease Patients Is Associated with Alterations in Circadian Rhythm. Dement Neurocogn Disord 2021;20.
[27]. Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A 2018;115.
[28]. Fenton L, Isenberg AL, Aslanyan V, Albrecht D, Contreras JA, Stradford J, et al. Variability in objective sleep is associated with Alzheimer’s pathology and cognition. Brain Commun 2023;5.
[29]. Chu H, Huang C, Miao Y, Ren C, Guan Y, Xie F, et al. The association of subjective sleep characteristics and plasma biomarkers of Alzheimer’s disease pathology in older cognitively unimpaired adults with higher amyloid-β burden. J Neurol 2023;270.
[30]. Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YES. Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol 2018;75.
[31]. Insel PS, Mohlenhoff BS, Neylan TC, Krystal AD, Mackin RS. Association of Sleep and β-Amyloid Pathology among Older Cognitively Unimpaired Adults. JAMA Netw Open 2021;4.
[32]. Harenbrock J, Holling H, Reid G, Koychev I. A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease. Biomark Neuropsychiatry 2023;9.
[33]. Roth T. Slow wave sleep: Does it matter? Journal of Clinical Sleep Medicine 2009;5.
[۳۴]. موسوی موحدی علی اکبر، فرهادی محمد، پیرحقی میترا. سبک زندگی و پزشکی خواب. نشاء علم، 1395;(2)06: 113-103.
[35]. Benedict C, Blennow K, Zetterberg H, Cedernaes J. Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men. Neurology 2020;94.
[36]. Targa ADS, Benítez ID, Dakterzada F, Fontenele-Araujo J, Minguez O, Zetterberg H, et al. The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients. Alzheimers Res Ther 2021;13.
[37]. Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, et al. Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease. Sci Transl Med 2019;11.
[38]. Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science (1979) 2019;363.
[39]. Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, et al. Review interaction between aβ and tau in the pathogenesis of alzheimer’s disease. Int J Biol Sci 2021;17.
[40]. Pulver RL, Kronberg E, Medenblik LM, Kheyfets VO, Ramos AR, Holtzman DM, et al. Mapping sleep’s oscillatory events as a biomarker of Alzheimer’s disease. Alzheimer’s and Dementia 2023.
[41]. Targa ADS, Benítez ID, Moncusí-Moix A, Dakterzada F, Minguez O, Vaca R, et al. Breathing cessation events that compose the apnea–hypopnea index are distinctively associated with the adverse outcomes in Alzheimer’s disease. Alzheimers Res Ther 2023;15.
[42]. Yang Y, Li M, Leng B, Yao R, Xue S, Tan M, et al. Alzheimer’s Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia. Journal of Alzheimer’s Disease 2023:1–12
[43]. Fernandes M, Chiaravalloti A, Manfredi N, Placidi F, Nuccetelli M, Izzi F, et al. Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer’s Disease Biomarkers. Journal of Alzheimer’s Disease 2022;88.
[44]. Cermakian N, Waddington Lamont E, Boudreau P, Boivin DB. Circadian clock gene expression in brain regions of Alzheimer’s disease patients and control subjects. J Biol Rhythms 2011;26.
[45]. Yoo ID, Park MW, Cha HW, Yoon S, Boonpraman N, Yi SS, et al. Elevated clock and bmal1 contribute to the impairment of aerobic glycolysis from astrocytes in alzheimer’s disease. Int J Mol Sci 2020;21.
[46]. Lananna B V., McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FHG, et al. Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer’s disease pathogenesis. Sci Transl Med 2020;12.
[47]. Cronin P, McCarthy MJ, Lim ASP, Salmon DP, Galasko D, Masliah E, et al. Circadian alterations during early stages of Alzheimer’s disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimer’s and Dementia 2017;13.
[48]. Hulme B, Didikoglu A, Bradburn S, Robinson A, Canal M, Payton A, et al. Epigenetic Regulation of BMAL1 with Sleep Disturbances and Alzheimer’s Disease. Journal of Alzheimer’s Disease 2020;77.
[49]. Araújo Pereira P, Alvim-Soares A, Aparecida Camargos Bicalho M, Nunes de Moraes E, Malloy-Diniz L, Jardim de Paula J, et al. Lack of Association between Genetic Polymorphism of Circadian Genes (PER2, PER3, CLOCK and OX2R) with Late Onset Depression and Alzheimer’s Disease in a Sample of a Brazilian Population (Circadian Genes, Late-Onset Depression and Alzheimer’s Disease). Curr Alzheimer Res 2016;13.
[50]. Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinklenberg JR, et al. Circadian clock gene polymorphisms and sleep-wake disturbance in alzheimer disease. American Journal of Geriatric Psychiatry 2011;19.
[51]. Chen Q, Peng XD, Huang CQ, Hu XY, Zhang XM. Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population. Genetics and Molecular Research 2015;14.
[52]. Qing-Xiu L, Chang-Quan H, Qian C, Xue-Mei Z, Xiu-Ying H, Song-Bing L. The polymorphism of ARNTL2 (BMAL2) gene rs2306074 C>T is associated with susceptibility of Alzheimer disease in Chinese population. Neurological Sciences 2014;35.
[53]. Bacalini MG, Palombo F, Garagnani P, Giuliani C, Fiorini C, Caporali L, et al. Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer’s disease and longevity in an Italian population. Geroscience 2022;44.
[54]. Mazzeo S, Bessi V, Bagnoli S, Giacomucci G, Balestrini J, Padiglioni S, et al. Dual effect of per2 c111g polymorphism on cognitive functions across progression from subjective cognitive decline to mild cognitive impairment. Diagnostics 2021;11.
[55]. Lozano-Tovar S, Rodríguez-Agudelo Y, Dávila-Ortiz de Montellano DJ, Pérez-Aldana BE, Ortega-Vázquez A, Monroy-Jaramillo N. Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease. Int J Environ Res Public Health 2023;20.
[56]. Bessi V, Balestrini J, Bagnoli S, Mazzeo S, Giacomucci G, Padiglioni S, et al. Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients. J Pers Med 2020;10.
[57]. Miao J, Ma H, Yang Y, Liao Y, Lin C, Zheng J, et al. Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials. Front Aging Neurosci 2023;15.
[58]. Deng Q, Wu C, Parker E, Liu TC-Y, Duan R, Yang L. Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances. Aging Dis 2023:0.
[59]. Clark GT, Yu Y, Urban CA, Fu G, Wang C, Zhang F, et al. Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates. PLoS Genet 2022;18.
